Harpoon Therapeutics HARP 深 沪
等待开盘 04-01 09:30:00 美东时间
23.01
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 23.01
- 总市值 4.92亿
- 52周最高 23.21
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.11
- 委 比 0.00%
- 总股本 2139.72万
- 历史最高 252.35
- 量 比 0
- 振 幅 0.00%
- 历史最低 5.44
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多AtaiBeckley Appoints Michael Faerm as Chief Financial Officer
AtaiBeckley Inc. announced the appointment of Michael Faerm as Chief Financial Officer, effective March 9, 2026. Mr. Faerm brings over 25 years of experience in life sciences, equity research, and investment banking. Anne Johnson, who has served as CFO since 2024, will transition to Chief Accounting Officer. The company is advancing BPL-003 toward Phase 3 and other clinical-stage programs.
02-19 12:00
跟紧风头，TCE三抗已然火热
日前，维立志博与风险投资公司Aditum Bio宣布成立新药研发公司Oblenio Bio，维立志博将其CD19/BCMA/CD3三特异性T细胞衔接器（TCE...
2024-11-11 12:04
美股生物制药并购潮掀起 谁将成为下一个潜在目标？
富国银行发布了其年度生物制药行业潜在并购清单，将减肥药开发商Viking Therapeutics(VKTX.US)、基因编辑公司CRISPR Therape...
2024-05-27 11:21
Viracta Therapeutics appoints Michael Faerm as CFO
Viracta Therapeutics (NASDAQ:VIRX) said it has appointed Michael Faerm as its CFO, effective immediately. Faerm has more than 25 years of experience in life sciences companies, equity research and inv...
2024-05-14 19:25
Oppenheimer Maintains Outperform on Harpoon Therapeuticsto Outperform
Oppenheimer analyst Hartaj Singh maintains Harpoon Therapeutics (NASDAQ:HARP) from Outperform to Outperform.
2024-03-26 22:03
美股收盘：三大指数涨跌不一 中概股普涨 B站大涨超13%
①热门中概股普涨，B站涨超13%； ②大型科技股涨跌不一，Meta跌超4%； ③甲骨文云营收高于预期，盘后大涨超13%。
2024-03-12 06:02
默沙东完成对Harpoon Therapeutics收购
默沙东公司3月11日宣布完成对Harpoon Therapeutics的收购，Harpoon的普通股将不再公开交易或在纳斯达克股票市场上市。
2024-03-11 20:26
